June 9, 2011 at 10:17
Lanic et al, EHA 2011
Related entries:
- 08/01/2011 - Lanic et al, Leuk Lymphoma 2012
- 06/09/2011 - Lanic et al, EHA 2011
Oral communication
16th Congress of the European Hematology Association (London, UK)
Non-Hodgkin Lymphoma - From biology to therapy #0478
Germinal Center B-cell signature is associated with higher [18F]-FDG uptake and improves the prognosis value of TEP-scan in DLBCL treated by Rituximab and anthracyclines based chemotherapy
Lanic H, Mareschal S, Mechken F, Picquenot JM, Cornic M, Maingonnat C, Bertrand P, Clatot F, Bohers E, Rainville V, Ruminy P, Bastard C, Tilly H, Becker S, Vera P, Jardin F
16th Congress of the European Hematology Association (London, UK)
Non-Hodgkin Lymphoma - From biology to therapy #0478
Germinal Center B-cell signature is associated with higher [18F]-FDG uptake and improves the prognosis value of TEP-scan in DLBCL treated by Rituximab and anthracyclines based chemotherapy
Lanic H, Mareschal S, Mechken F, Picquenot JM, Cornic M, Maingonnat C, Bertrand P, Clatot F, Bohers E, Rainville V, Ruminy P, Bastard C, Tilly H, Becker S, Vera P, Jardin F
Abstract book, Haematologica